
Healthcare and medicine · OncologyResearch and development · BiotechnologyHealthcare and medicine · General Medicine
The FDA has approved the first drug for pancreatic cancer.
The United States has approved the first direct-acting drug for the treatment of late-stage pancreatic adenocarcinoma, one of the most aggressive forms of cancer. The new medication has demonstrated a twofold improvement in survival rates compared to standard chemotherapy.
0 —
